Analyst Expectations For Celldex Therapeutics's Future
Analyst Expectations For Celldex Therapeutics's Future
塞德斯医疗未来的分析师期望
In the preceding three months, 5 analysts have released ratings for Celldex Therapeutics (NASDAQ:CLDX), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有5位分析师公布了Celldex Therapeutics（纳斯达克股票代码：CLDX）的评级，提出了从看涨到看跌的各种观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $77.4, a high estimate of $80.00, and a low estimate of $67.00. This current average has not changed from the previous average price target.
分析师12个月目标股价的见解已经公布，平均目标股价为77.4美元，最高估计为80.00美元，低估值为67.00美元。当前的平均价格与之前的平均目标价格相比没有变化。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
A comprehensive examination of how financial experts perceive Celldex Therapeutics is derived...
对金融专家如何看待Cel...
登录免费看全文
登录/注册